NEW YORK (GenomeWeb) – Alere said today the US Food and Drug Administration has granted 510(k) clearance of its Alere i Influenza A & B 2 test for the faster detection of influenza A and B infection in children and adults.
Alere said that the test is a second-generation rapid molecular assay that delivers lab-accurate results and has the ability to report a positive result in as little as five minutes.